Who owns MOONLAKE IMMUNOTHERAPEUTICS?

Tip: Access positions for across all investors

Analyze quarterly positions in Moonlake Immunotherapeutics with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Moonlake Immunotherapeutics stock

Who bought or sold MOONLAKE IMMUNOTHERAPEUTICS this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
IMC-Chicago 37k $488k 100% Dec 2025
 View chart
Simplex Trading 33k $436k -84% Dec 2025
 View chart
Group One Trading 31k $402k -75% Dec 2025
 View chart